Head-To-Head: Hargreaves Lansdown plc’s New High Income Fund vs GlaxoSmithKline plc, Unilever plc And Imperial Brands plc

Does the new High Income Fund from Hargreaves Lansdown plc (LON: HL) match what’s on offer from GlaxoSmithKline plc (LON: GSK), Unilever plc (LON: ULVR) and Imperial Brands plc (LON: IMB)?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

After seven years of ultra-low interest rates, investors and savers alike have seen numerous alternative methods of obtaining an acceptable yield on their savings income. Traditional, safer, savings accounts are covered up to £75k for individual accounts and £150k for joint accounts per institution. But savers seeking an acceptable return on their nest eggs have been forced to look elsewhere – even where there’s more risk.

Appealing to the ‘grey’ pound

One thing’s clear from the demographics at play in the UK and in certain other parts of the developed world, the population as a whole is living longer. I could write about the many moving parts that are at work behind the scenes. However, I’m focusing on how companies are looking to serve the opening in the market that I expect to grow significantly over the next few years as baby boomers reach retirement age and start to look for income to replace that lost from employment.

And when I received my copy of Investment Times from asset manager Hargreaves Lansdown (LSE: HL) I noticed a new Multi-Manager High Income Fund launch that appears to be positioned to tackle the lack of income on offer from banks.

The new fund will be led by Lee Guardhouse and Ellen Powley who will seek to deliver a sustainable high income, distributed on a monthly basis. Though the yield at the launch price of £1 is expected to be around an above-average 4.5%, as with all riskier investments, this is variable and not guaranteed.

In order to smooth any volatility, the fund will invest in the managers’ favourite funds that are themselves investing in both shares and corporate bonds. Initially the managers are eying a 60/40 split in favour of funds investing in shares, though obviously this could change over time in order to achieve the best result for clients as the economy ebbs and flows.

Is there a better way?

I have to say that if I were a novice investor with a lump sum to invest for regular income, I would be tempted by the Hargreaves offering. However, as with all funds, investors need to keep a watchful eye on charges, both in terms of the underlying investments of the funds within the fund, and the fund itself.

Accordingly, as a slightly more experienced investor, I tend to lean towards shares of individual companies that in my view offer income, with growth in earnings that should translate into an increased dividend as time goes by.

To that end, I’ve selected three shares which look to fit the bill:

  • GlaxoSmithKline (LSE: GSK) the global healthcare company that researches and develops pharmaceuticals, vaccines and consumer healthcare products – forward yield of 5.89%
  • Unilever (LSE: UNLR) the global consumer defensive giant engaged in the supply of food, home and personal care products – forward yield of 2.96%
  • Imperial Brands (LSE: IMB) formerly Imperial Tobacco, a global fast-moving consumer goods company focused on a tobacco portfolio that offers a range of cigarettes, fine cut and smokeless tobaccos, plus papers and cigars – forward yield of 4.29%

Taken together, these three stocks yield an above average 4.38% that I expect to grow over time, and importantly, as depicted by the chart, they’ve also outperformed the FTSE 100 over the last 12 months.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Dave Sullivan owns shares in Imperial Brands. The Motley Fool UK owns shares of and has recommended Unilever. The Motley Fool UK has recommended GlaxoSmithKline and Hargreaves Lansdown. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »